TABLE 5.
Top 10 active pharmaceutical ingredients/products by the number of reports in the EV pharmacovigilance database.
| Name of API/product | API | PRR (95%CI) | RRR (95%CI) | ROR (95%CI) | Number of cases for this drug |
|---|---|---|---|---|---|
| Clopidogrel | Clopidogrel | 25.93 (21.19–31.73) | 23.43 (19.17–28.65) | 25.98 (21.23–31.79) | 105 |
| Bevacizumab | Bevacizumab | 20.03 (15.77–25.46) | 18.73 (14.77–23.82) | 20.06 (15.79–25.49) | 72 |
| Insulin | Insulin | 5.99 (4.65–7.74) | 5.70 (4.42–7.35) | 6.00 (4.65–7.74) | 63 |
| Sildenafil | Sildenafil | 42.16 (32.47–54.73) | 39.80 (30.67–51.65) | 42.29 (32.58–54.90) | 60 |
| Rivaroxaban | Rivaroxaban | 5.40 (4.12–7.09) | 5.17 (3.95–6.79) | 5.41 (4.12–7.09) | 55 |
| Entecavir | Entecavir | 161.26 (119.79–217.10) | 154.24 (114.59–207.58) | 163.32 (121.31–219.87) | 46 |
| Pregabalin | Pregabalin | 8.51 (6.21–11.68) | 8.23 (5.99–11.28) | 8.52 (6.21–11.69) | 40 |
| Tadalafil | Tadalafil | 42.47 (30.83–58.51) | 40.93 (29.71–56.37) | 42.61 (30.93–58.69) | 39 |
| Abatacept | Abatacept | 10.91 (7.01–17.00) | 10.73 (6.89–16.70) | 10.93 (7.02–17.01) | 20 |
| Tenofovir | Tenofovir | 142.10 (91.06–221.75) | 139.41 (89.35–217.53) | 143.74 (92.11–224.30) | 20 |